has been developed in the rat after subcutaneous administration of SK&F 95654. Administration of this potent PDE III inhibitor induced an arteriopathy of mesenteric arteries within 24 hr that was dose-related in intensity and incidence over the range 0.174, 0.348, 0.523, and 0.697 mmol/kg. The arteriopathy was restricted to muscular arteries of external diameter of 100-800 &mu;m and was shown microscopically to be focal or segmental medial necrosis and hemorrhage. A time-course experiment, conducted from 3 to 24 hr postdosing, showed that the first changes observed 6 hr postdosing were on the endothelium followed by focal hemorrhages into the media at 12 hr postdosing, causing compression, degeneration, and necrosis of myocytes. From 16 hr postdosing, there was focal endothelial cell necrosis and loss of confluence. Leukocytes and activated platelets were found adhering to exposed basement lamina and seen to pass through endothelial gaps into the subintima. By 24 hr postdosing, medial necrosis was extensive with large areas of media replaced by erythrocytes, cell debris, and a few leukocytes and platelets.
INTRODUCTION
Phosphodiesterase III (PDE III) inhibitors are potent inotropic/vasodilators due to inhibition of the cGMP-inhibitable isozyme of phosphodiesterase with consequent elevation of [cAMP]i in cardiac myocytes and vascular smooth muscle (11, 24, 33, 34, 36) . PDE III inhibitors induce an epicardial arteriopathy in the dog following multiple administration of these compounds at suprapharmacological doses (13) . The initial morphological changes induced by these compounds has been characterized following a single high dose of a potent PDE III inhibitor, SK&F 95654, to dogs (17) , but the pathogenesis of this toxic effect has not been determined. Furthermore, although PDE III inhibitors are potent vasodilators at pharmacological doses (6, 11, 30) the hemodynamic effects of these agents at toxicological doses have not been fully defined.
Fenoldopam, a drug developed for the clinical management of congestive heart failure, is also a potent vasodilator due to DA, receptor-mediated stimulation of adenylate cyclase (12, 27) with resulting elevation of vascular smooth muscle [cAMP] i. The pharmacological action of fenoldopam and PDE III inhibitors as vasodilators is therefore due to the same biochemical event, namely increased cAMP in arterial smooth muscle. Administration of fenoldopam has been documented as producing an arteriopathy in the splanchnic vasculature of rats following 24 hr continuous iv infusion (40) . The arterial toxicity induced by fenoldepam has been related to its pharmacological effect (18) , and it was postulated that at high doses PDE III inhibitors would also induce a splanchnic arteriopathy. More recently, Westwood et al (38) reported the induction of morphologically similar arterial lesions following administration of the PDE III inhibitor ICI 153,110 to rats.
Findings from preliminary studies have confirmed that sc administration of fenoldopam (90 mg/kg sc) and SK&F 95654 (200 mg/kg sc) induced identical arterial lesions at 24 hr postdosing, principally in muscular arteries in the mesentery, pancreas, and spleen (unpub- lished data). Lesions were most extensive and reproducible in the mesenteric vasculature and consisted of segmental medial hemorrhage and necrosis. The mesenteric vasculature was therefore used in the present investigations into the pathogenesis of this arteriopathy. The specific aims of the present study using the rat were the following: . To investigate the dose-response for the induction of lesions by SK&F 95654 in the mesenteric arteries of rats and to correlate the effect with changes in systemic arterial pressure.
. To compare the relative potential of 4 Systolic blood pressure was measured in Experiments 1 and 2 from the caudal artery of conscious rat using a plesthysmography method (IITC model 29, CA, USA). The plesthysmographic method was validated in a separate series of experiments by simultaneous comparison of invasive and plesthysmographic blood pressure determinations under normotensive and pharmacologically induced hypotensive states (mean blood pressure range 50-130 mm Hg; correlation coefficient = 0.939).
Necropsy
Macroscopic Examination. Rats were sacrificed by carbon dioxide inhalation, and the abdominal cavity was opened. The mesenteric vasculature was perfuse-fixed with modified saline followed by Kamovsky's fixative at a pressure of 100 mm Hg following cannulation of the left ventricle of the heart. The exposed mesenteric arterial bed consisted of an elastic superior mesenteric artery and up to 14 first-order muscular branch arteries of 500-800 [tm external diameter, which branched to result in secondto fourth-order arteries supplying the duodenum, ileum, jejunum, and cecum. The intestines were spread on a cork board and held in place by pins at the mesentery/ intestinal border. After removal of the mesenteric lymph nodes, mesenteric arteries were examined by stereomicroscopy.
The degree of arteriopathy was graded according to the following criteria: Microscopic Examination. Up to 3 firstto secondorder mesenteric arteries were sampled (minimum of 20-40 mm longitudinal segments) for light microscopy according to the following criteria: first-order mesenteric arteries with macroscopic lesions were sampled from rats with mild lesions whereas the first-order ileal mesenteric artery was sampled from rats with moderate and severe lesions.
Twelve to 30 transverse serial sections of nominal 4 /-Lm thickness were prepared and stained with hematoxylin and eosin (H&E). The sectioning procedure ensured that macroscopically normal and abnormal areas were sampled. In addition, the superior mesenteric artery immediately adjacent to the sampled first-branch artery was also sampled and processed histologically. For 1 SK&F 95654-treated rat, a section of affected artery was also stained with phosphotungstic acid haematoxylin (PTAH) for visualization of fibrin.
Arteries were processed by standard histological techniques to produce wax-embedded, H&E-stained sections for light microscopy. For serially sectioned arteries, the incidence of findings were graded according to the percentage of the medial area affected by hemorrhage and necrosis using the following criteria: Minimal = <I 0% of circumference area (+). Mild = 10-50% of circumference area (++). Moderate = 50-90% of circumference area (+++). Marked = 100% of circumference area (+ + + +).
The grade of lesion reported is the maximum observed.
Individual Study Designs Experiment 1: To Investigate the Dose-Response Relationship of Mesenteric Arteriopathy and Hypotension Induced by SK&F 95654. Five rats/dose group were administered 0, 0.174, 0.348, 0.523, and 0.697 mmol/kg SK&F 95654 subcutaneously, and the mesenteric vasculature was examined macroscopically 24 hr postadministration. The first-order branch, mtsenteric vasculature was examined microscopically using H&E paraffin sections. Further groups of 5 rats were dosed subcutenously at 0, 0.174, or 0.697 mmol/kg, and systolic blood pressure was measured from conscious rats using a validated plesthysmography method over the period 0.5-24 hr. The degree of hypotension was correlated with the incidence and severity of macroscopic mesenteric arterial lesions. ously to groups of 8 rats at doses of 0 and 0.697 mmolfkg and the mesenteric vasculature examined macroscopically 24 hr postadministration. The first-order branch mesenteric vasculature was examined microscopically by H&E paraffin sections. For each compound (except SK&F 95654, where data were already available from Experiment 1), the effects on systolic blood pressure was determined over the period 1-24 hr from further groups of 5 rats dosed at 0 and 0.697 mmol/kg. The incidence and severity of mesenteric arterial lesions were also examined macroscopically at the end of this period and correlated with the hypotension induced by these agents. Experiment 3: To Investigate the Time Course of Mesenteric Arteriopathy. Five rats/time point were dosed subcutaneously with 0.697 mmol/kg SK&F 95654 subcutaneously at 2 ml/kg and sacrificed 3, 6, 12, 16, 20, and 24 hr postadministration. A control group of 5 rats was dosed with vehicle only (DMSO), and these rats were sacrificed 24 hr postadministration. In all cases, the mesenteric vasculature was perfused with modified Karnovsky's fixative and examined macroscopically. Segments of first-branch mesenteric arteries were processed to produce longitudinal sections for standard histology (H&E).
Segments of first-branch ileal arteries from 2 rats/ group were also processed for scanning (SEM) and transmission electron microscopy (TEM). For SEM examination, the arteries were carefully transected longitudinally with glass knives, dehydrated in increasing concentrations of acetone, critically point dried, fixed onto stubs, coated with a thin layer of gold, and examined in a standard electron microscope (model XL 20, Philips Analytical N.V., Eindhoven, The Netherlands) at 10 kV. For TEM, arteries were secondarily fixed in osmium tetroxide, dehydrated in increasing concentrations of ethanol, and embedded in Araldite CY 212 resin to produce longitudinal sections. Sections for light microscopy (1 [tm) were stained with Humphreys' stain, examined without knowledge of treatment allocation, and used to select arteries for TEM. For TEM, ultrathin sections were stained with uranium and lead salts.
Statistical Methods
Blood pressure data were evaluated by analysis of variance of the area under the blood pressure curve (AUC), followed by comparison of pre-and postdose results for significant intergroup comparisons, by Student's t-test for paired comparisons. The correlation between magnitude of the blood pressure response (AUC) and severity of the macroscopic mesenteric arterial lesion was determined using a ranked correlation test (35) . For each statistical analysis, p S 0.05 was considered to be significant.
RESULTS

Clinical Observations: Experiments 1-3
PDE III Inhibitor-Induced Mesenteric Arteriopath) and Blood Pressure Effects. SK&F 95654 was well tolerated over the dose range 0.174-0.697 mmol/kg. The only effect was a transient lethargy, dose-related in intensity and duration. This effect was evident within 3C min postdosing and lasted for approximately 3 and 6 hi at 0.174 and 0.697 mmol/kg, respectively. Associate( with lethargy, the pinnae and paws of the animals were reddened due to peripheral vasodilation. A similar, tran sient lethargy was also noted following administration o 0.697 mmol/kg WIN 62582 but not SK&F 94120 or SK&F 94836.
Blood Pressure Investigations Experiment 1. The systolic blood pressure obtained over the period 0.5-24 hr post-SK&F 95654 administration is shown in Fig. 2 . Administration of 0.174 and 0.697 mmol/kg SK&F 95654 produced decreases of 30 and 37%, respectively, in systolic pressure 1 hr postdosing ; both changes were statistically significant (p < 0.01). The duration of hypotension was dose-related, returning to control values 4 hr after administration of 0.174 mmol/kg and 12 hr after administration of 0.697 mmol/ kg. There was considerable interanimal variation in the systolic blood pressure readings, a frequent issue with the plethysmographic method of blood pressure recording in the conscious rat. The decrease in blood pressure at 0.697 mmol/kg was only statistically significant over the period 0.5-5 hr postdosing (p < 0.001). Experiment 2. WIN 62582 produced a decrease in blood pressure that was maximal at 3 hr postdosing (35% reduction in systolic blood pressure, significant at p < 0.01). The hypotension lasted until 10 hr postdosing. In contrast, SK&F 94120 had no measurable hypotensive effect, whereas SK&F 94836 administration resulted in a transient decrease in blood pressure (maximal decrease 24% at 3 hr postdosing) with systolic blood pressure returning to control levels by 4 hr postdosing. The blood pressure data for WIN 62582 and SK&F 94120 are shown graphically in Fig. 3 (SK&F 94836 blood pressure data omitted from figure for clarity).
Macroscopic Findings
No macroscopic abnormalities were observed in control mesenteric branch or superior mesenteric branch arteries. Experiment 1. At 24 hr postdosing, there was a doserelated incidence and severity of segmental mesenteric arterial lesions at doses of 0.174-0.697 mmol/kg SK&F 95654 ( Fig. 4a ). Lesions were found in arteries of ca. 100-800 lim external diameter ( Fig. 5 ) and were focal, annular, or confluent hemorrhages (Fig. 6 ), often associated with extravasated Monastral blue B dye. At 0.174 mmol/kg, 60% of animals showed macroscopic lesions characterized by single foci of Monastral blue B in the arterial wall of 1-3 arteries. At 0.697 mmol/kg, 100% of animals showed macroscopic lesions with 85% of animals in this group developing lesions ranging from multifocal hemorrhage with Monastral blue B inclusion in the wall of branch arteries to arteries with confluent hemorrhage. The first-order branch arteries showed the great- -Blood pressure profile (mean and standard error of systolic pressure) over a 24-hr period following SK&F 95654 administration at 0.174 and 0.697 mmol/kg. teric artery, not even in animals with severe lesions in first-order branch arteries. There was a consistent, distinct demarcation at the junction of the first-order branches and the superior mesenteric artery. Experiment 2. There were clear differences in the potential for the 4 PDE III inhibitors to induce mesenteric arteriopathy at a dose of 0.697 mmol/kg (Fig. 4b ). The incidence and severity of the lesions obtained with these compounds were ranked in the following order: SK&F (rs = 0.595, p < 0.01) and WIN 62582 (r, = 0.70, p < 0.05). Experiment 3. The incidence of macroscopic findings in the time-course study is shown in Fig. 9 . No macroscopic findings were observed in controls or rats sacrificed 3 hr postdosing. The first lesions noted were at the junction of the superior mesenteric artery and first-branch artery. At 6 hr postdosing, very small foci of Monastral blue B deposition in the artery was noted in 4 of 5 rats. At 12 hr, small hemorrhagic and Monastral blue B foci were noted at this location in 4 of 5 rats. The incidence of macroscopic lesions was far greater in rats examined 16-24 hr postdosing. All rats at these time points (15 of 15) showed multiple segmental hemorrhagic foci with a morphology identical to that described previously; 14 of 15 of these lesions were graded moderate or severe.
Microscopic Findings
The morphology of control arteries was consistent with that described previously from untreated, normotensive rats. Whole-body perfusion resulted in distended arteries with well-preserved intimal, medial, and advential tuni- 62582, the extent of the medial lesion ranged from small discrete foci or segmental areas of necrosis and hemorrhage, occupying less than 10% of the arterial circumference, to a severe hemorrhagic necrosis affecting 100% of the medial circumference. In minimally affected arteries, areas of hemorrhage and necrosis were often surrounded by smooth muscle cells of normal appearance. Occasionally, single or multiple foci of necrotic smooth muscle cells were observed.
In severe lesions, the whole of the media was filled with extravasated erythrocytes (Fig. 7) and adventital hemorrhage was also observed. Histochemical stains for fibrin were negative. The eas. In lesions graded as moderate or marked, there was a low incidence of polymorphonuclear and mononuclear leukocytes in the media, and frequently an acute inflammation (polymorphonuclear and mononuclear cells) was observed in the adventitia.
No evidence of endothelial necrosis was seen in SK&F 95654-treated animals by light microscopy, and intimal changes were largely limited to pavementing of leukocytes in treated animals; focal endothelial loss with leukocyte attachment was observed for 1 WIN 62582-treated rat.
No lesions were observed in the elastic superior mesenteric artery, although lesions were frequently observed at the junction with the muscular, first-branch artery (Fig.   5 ). Arteries stained for elastin showed that lesions induced by SK&F 95654 and WIN 62582 at this junction occurred at the point where the multiple elastic lamella are reduced to a single internal elastic lamella (Fig. 8 ).
Arteries from SK&F 94836-treated animals were examined by light microscopy, but no lesions were observed. Because no macroscopic lesions were observed for SK&F 94120-treated rats, mesenteric arteries from this group were not examined microscopically.
Experiment 3. Light and Electron
Microscopy Findings Control Group. Light and electron microscopy confirmed that all arteries were well preserved. By SEM, the luminal surface was characterized by a continuous layer of closely abutting endothelium with clear junctions and a few microvilli (Fig. 10 ). By TEM, endothelial cell nuclei appeared elongate, endothelial junctions were observed as overlaps of cytoplasm with several tight junctions, and the cytoplasm contained the usual complement of lysosomes and small &dquo;plasmalemmal&dquo; vesicles. There was no evidence of separation of endothelial cells, a few erythrocytes and white blood cells were found on the endothelial surface, but there was no evidence of platelel aggregation (Fig. 10 ). SK&F 95654-treated Group. 3 
and 6-Hr Time Points:
There were no obvious changes at the 3-and 6-hr time points; however, in 1 rat at 6 hr postdosing, individual endothelial cells appeared raised and the interendothelia projections were more pronounced when examined b) SEM (Fig. 11 ). 12 95654 showing segmental, distensive medial necrosis and hemorrhage (h) interspersed with apparently normal media (arrowheads). This lesion was graded as marked; note apparently normal endothelium (e). X250.
FIG. 8.-Longitudinal section through the junction between the superior mesenteric artery (sma) and a mesenteric first-branch artery from a rat 24 hr after a single sc dose of 0.697 mrnol/kg SK&F 95654. Medial necrosis and hemorrhage (h) are present at the junction of the 2 vessels beginning where the multiple elastic lamellae of the sma are reduced to the single internal elastic lamella of the branch artery (arrow). The medial hemorrhage has extended out into the adventitia (arrowhead). Elastic Van Gieson stain. X250. examined showed 1-5 discrete foci of 5-10 erythrocytes within the media immediately adjacent to the internal elastic lamella with necrosis of 1-2 smooth muscle cells. This was confirmed by TEM, which showed that erythrocytes were present in medial voids with associated compression, degeneration, and necrosis of surrounding smooth muscle cells (Fig. 12 ). TEM showed that medial cells away from the immediate vicinity of the erythro-cytes had a normal range of structure. SEM examination of the luminal surface of affected arteries showed evidence of separation of endothelial junctions. 16 -Hr Time Point: At 16 hr postdosing, the medial hemorrhage and necrosis was more extensive and segmental. In addition to focal hemorrhage and necrosis, transmural medial necrosis and hemorrhage were ob- confluence and/or necrosis of individual cells (Figs. 13 and 14) . Leukocytes and activated platelets were noted on the underlying basement lamina of necrotic or contracted endothelial cells (Fig. 13 ). Focal interendothelial gaps were also seen, with passage of activated platelets and leukocytes between the endothelium (Fig. 14) . TEN confirmed increased severity of focal erythrocyte extrav asation in the media, with increased compression of sur rounding smooth muscle cells. In loss of smooth muscle cell structure and substantial cellular debris (Fig. 15 ). These lesions also contained extravasated platelets and polymorphonuclear and mononuclear leukocytes (Fig. 16 ). Focal breaks in the internal elastic lamella, with protrusion of degenerate or necrotic endothelial cell cytoplasm into the medial space, were associated with severe medial lesions. 20 and 24-Hr Time Points: Light microscopy showed progressive lesion development with increased medial necrosis and hemorrhage distending the arterial wall in 30% of the rats. The adventitia below medial lesions often showed a polymorphonuclear and mononuclear leukocyte-rich inflammatory infiltrate accompanied by edema. The endothelium appeared apparently normal by TEM in all animals apart from I rat, where individual endothelial cell necrosis was characterized by a nuclear condensation, swelling, and disruption of organelles with fragmentation of the cytoplasm (Fig. 17 ). These endothelial changes were associated with multiple breaks in the internal elastic lamina and degeneration of underlying medial smooth muscle cells. A low incidence of fibrillar material was noted in areas of extensive medial damage and in the associated adventitia. This was not definitively confirmed as fibrin in spite of extensive examination of this material for its characteristic electron microscopic pattern. SEM revealed progressive effects on endothelial integrity, with greater numbers of leukocytes and activated platelets found on the underlying basement lamina There is a single focus of eiythrocytes (E) in the media closely apposed to what was thought to be a degenerate myocyte (arrowhead). The overlying endothelium (e) and smooth muscle cells a short distance from the erythrocytes are apparently normal. An apparent break in the internal elastic lamella (iel) is also shown. x 6,000. (14, (20) (21) (22) , the site of predilection was quite different. In the rat, acute administration of SK&F 95654 has the potential to induce arteriopathy in the splanchnic vasculature, particularly the mesenteric arteries, rather than the epicardial coronary arteries or other anatomical sites, with the exception of minimal lesions in the saphenous artery and renal artery (unpublished observations).
The distribution of SK&F 95654-induced arterial lesions in the rat contrasts with those noted for the dog where the epicardial vasculature is the site of predilection (14) . The reason for the different sites of predilection between the 2 species is not immediately obvious, although it may be related to the relative pharmacological responses of these arterial segments (20) or their anatomical position. For example, studies of the internal carotid and vertebral arteries in spontaneously hypertensive rats suggest that the physical properties of supporting tissue may modify showing a group of platelets at the junction between 2 endothelial cells (e) and an interendothelial gap with platelets (p) and a leukocyte (1) presumed to be passing into the subintimal layer. A further group of platelets (P) are also present on the endothelial surface. SEM. X7,000. the effect of elevated blood pressure on the vessel wall.
Arteries supported within the bony canals were shown to have less medial thickening than in unsupported arteries (26) . The pathogenesis of arteriopathy following vasodilation has not been determined; however, 2 theories have been proposed. One relates to the role of vascular tone (20, 38) and the second to elevation of cAMP in vascular smooth muscle (16) .
An arteriopathy of similar morphology to that induced by SK&F 95654 has been previously reported in the rat following administration of a number of vasodilating compounds. The PDE III inhibitor ICI 153,110 (38) induced medial necrosis and hemorrhage, principally in the mesenteric arteries although the arterial lesions were also noted in the arteries of the splanchnum, heart, testis, and pampiniform plexus. Clinical evidence of vasodilatation was noted at 250 mg/kg ICI 153,110 po and, in a limited investigation, a 19-24-mm Hg decrease in systolic blood pressure was observed at 3 hr postdosing (only postdose blood pressure recording, baseline blood pressure data not reported). Mesenteric arterial lesions have also been reported in the rat following chronic administration of 2 other PDE III inhibitors, isomazole and indolodan (31, There is necrosis of a smooth muscle cell (M). Note platelet (p), apparently fragmented internal elastiq lamella (arrowhead), and continuous endothelium (e). X3,600. 32), although in these studies blood pressure was not reported. Furthermore, chronic administration of nonspecific PDE inhibitors caffeine (15) and theophylline (4) has resulted in increased incidence of polyarteritis in the rat including mesenteric vessels. The arterial lesions following theophylline administration were characterized by infiltration of mononuclear and polymorphonuclear leukocytes in the adventitia and media, with proliferation of connective tissue in the adventitia and enlarged subendothelial spaces. Following 80 wk of caffeine administration, nodular thrombotic arterial lesions were observed with medial fibrinoid necrosis and inflammatory infiltration ; 4 rats treated with caffeine died following rupture of the damaged vessels and subsequent intraabdominal hemorrhage.
The dopaminergic (DA,) agonist vasodilator, fenoldopam, induces segmental arteriopathy in large-caliber (20-250 u.m luminal diameter) splanchnic, ovarian and renal arteries following a 24-hr infusion at doses of 5-100 /-Lg/ kg/min (23, 40) . This lesion was morphologically identical to that induced by SK&F 95654 and occurred most frequently in splanchnic arteries with a media comprised of 4-5 layers of medial smooth muscle cells. Treatmentrelated ultrastructural effects have also been reported after 24 hr continuous infusion of fenoldopam at 5-100 VLg/ kg/min (1) . In mild areas of arterial damage, the medial cells contained intracytoplasmic pseuodovacuoles, auto- There is necrosis of smooth muscle cells (M) and extravasated erthyrocytes (E) and platelets (p) in the media. Note also internal elastic lamella (iel) and a continuous endothelium (e). X 3,600. phagic vacuoles, and electron-dense myofilamentous inclusions. For more severe lesions, overt medial necrosis and hemorrhage were noted that were identical to those induced by SK&F 95654 in fully developed lesions. Changes to the endothelium were not observed in fenoldopam-treated rats except in areas of severe medial damage, and the mechanism responsible for the extravasation of erythrocytes was not determined. However, the electron microscopic evaluation of fenoldopam did not include a detailed examination of the endothelial surface by SEM and therefore focal interendothelial gaps may not have been observed. The morphological development of the SK&F 95654 arteriopathy was investigated over a 24-hr period postdosing. The SEM and TEM of control and SK&F 95654-treated rats sacrificed up to 3 hr postdosing was normal with a structure consistent with previously reported ultrastructure of vascular smooth muscle (1, 2, 7, 28) . The initial SK&F 95654-related abnormality observed by light microscopy and TEM was focal erthrocytic extravasation into the subintimal media with associated smooth muscle cell degeneration at 12 hr postdosing. Although interendothelial gaps were not observed by TEM concurrently with these initial medial effects, treatment-related effects were observed by SEM from 6 hr postdosing with endothelial separation at 12 hr. Distinct focal endothelial gaps were noted at 16-24 hr with adhesion of leukocytes and platelets and passage of these formed elements into the subintima. It is possible that the interendothelial gaps observed in this study are the consequence of passive stretching of the endothelium as a result of vasodilation. In an interesting study (5) , it was shown that focal dilation of the arterioles over the cremaster muscle of the rat following nonspecific irritation resulted in interendothelial gaps with platelet adhesion. The media were focally thickened by colloidal marker, plasma, lipoproteins, and fibrin with occasional platelets and red blood cells. There was rare evidence for smooth muscle cell necrosis and stretching in areas of focal dilation. Lesions were more severe if the pellets were impregnated with histamine (resulting in additional vasodilation) but attenuated by 5-hydroxytryptamine (producing constriction).
Arterial lesions have also been reported in animals and humans following elevation of blood pressure. Thickening of the media of arteries due to hypertrophy and hyperplasia as an adaptive process to a slowly developing increase in blood pressure is a hallmark of chronic hypertension in humans and hypertensive rats (19) . More destructive forms of arterial lesions are induced in the rat by rapidly developing forms of hypertension induced by the acute administration of vasoconstrictors such as angiotensin II (3, 8, 10, 29, 37, 39) . Although there has been debate concerning whether or not an initial vasoconstriction precedes dilation in the pathogenesis of arterial lesions following hypertensive doses of vasocon-strictor compounds, there is general agreement that the arterial lesions occur at dilated segments of the vessel (9, 10, 37). Nemes et al (25) investigated the effect of acute iv administration of angiotensin II on rat arteries and postulated that the resulting vascular medial necrosis induced by elevated blood pressure was due either to excessive vasopressor-induced vasoconstriction or from local vasodilation that increases the local wall tension beyond a critical level. Arterial lesions induced by vasodilators of different biochemical basis of pharmacological actions in the rat and dog have also been explained by increased intramural tangential stress. Mesfin et al (20) has proposed that the coronary arterial lesions induced by minoxidil in dogs were the consequence of arterial distension and considered the smooth muscle cell to the principal cell type affected. Furthermore, fenoldopam at the 100-/-Lglkg/min dose that induced splanchic arterial lesions in the rat also produced a 10-20% decrease in mean arterial pressure throughout the 24-hr infusion period (1) . Fenoldopam is a potent vasodilator and has been shown in vitro to reduce perfusion pressure in methoxamineconstricted isolated ileal arteries of the rat (16) at a concentration of 10-7 M. In common with the hypothesis of vasodilator-induced arteriopathy in the dog (20) , it has been suggested that prolonged reductions in blood pressure following fenoldopam administration, together with alterations in intramural tension resulting from vasodilation, may be implicated in the pathogenesis of the arteriopathy induced by this compound (1, 16) . It has also been proposed (38) that the arterial medial necrosis induced in the rat by the PDE III inhibitor ICI 153,100 was due to excessive vasodilation, which resulted in the critical intramural tension being exceeded. However, a detailed determination of the hemodynamic effects of PDE III compounds at toxicological doses has not been previously reported. The present investigations demonstrated that the severity of the mesenteric arteriopathy induced by SK&F 95654 was closely correlated with the extent and duration of the hypotension induced at these toxicological doses. The close relationship between the hypotensive potency of the other PDE III inhibitors evaluated (WIN 62582 > SK&F 94836 > SK&F 94120) and their ability to induce mesenteric arteriopathy also confirmed this association. Systolic blood pressure alone, however, is only an indirect indication of hemodynamic changes in the mesenteric vasculature. Determination of blood flow in the superior mesenteric artery of the rat (Gardiner and Joseph, unpublished observations) has demonstrated an increase in conductance (maximum 85%) following 0.697 mmol/kg sc SK&F 95654 that lasted over the 24-hr observation period.
It is of interest that SK&F 94120 at equimolar doses to SK&F 95654 did not induce macroscopically visible foci of hemorrage or Monastral blue B in first-branch mesenteric arteries, even though these vessels were closely examined with the aid of a stereomicroscope. Significantly, under the conditions of the experiment, SK&F 94120, in contrast to the other PDE III inhibitors evaluated, did not produce any significant hemodynamic effect. Furthermore, in an anesthetized rat model, SK&F 94120 at the same doses as those used in these experi-ments failed to produce significant effects on mean arterial pressure, mesenteric blood flow, or hindlimb blood flow (Joseph, unpublished observations) . In contrast, SK&F 94120 has been reported to induce coronary arterial lesions in the dog at doses that produced substantial hemodynamic effects, including an approximately 40% decrease in mean blood pressure and an increase in ventricular contractility (12) . Arteries from SK&F 94120treated rats were not examined microscopically and it is possible that small focal lesions were overlooked. However, the lack of a pharmacologic response following sc administration of SK&F 94120 at 0.697 mmol/kg in the rat is likely to have been a major factor for the absence of macroscopic arterial lesions following administration of this compound.
In conclusion, the administration of structurally dissimilar PDE III inhibitors induces a dose-related segmental necrosis and hemorrhage in the media of rat mesenteric arteries of 100-800 /-Lm diameter. The arterial lesions observed following SK&F 95654 administration over the period 6-24 hr were (a) abnormal endothelial permeability with opening of endothelial junctions, (b) small foci of subintimal hemorrhage and necrosis at 12 hr postdosing, (c) subsequent progression to transmural necrosis and hemorrhage by 20-24 hr postdosing. There was a close correlation between the magnitude and duration of the hypotension induced by SK&F 95654, WIN 62582, and SK&F 94826 and the severity of the mesenteric arteriopathy in the rat. These findings, together with the prolonged increases in mesenteric blood flow induced by SK&F 95654, suggest that long-lasting and excessive increases in arterial compliance may lead to both abnormal endothelial permeability and medial necrosis. It is postulated that the endothelial changes permit the ingress of plasma proteins, inflammatory cells, and possible release of cytokines. These changes, together with the previously identified increase in medial wall tension as a consequence of arterial distension, may be important aspects in the pathogenesis of vasodilator-induced arterial lesions.
